Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition

We report the implementation of our in silico/synthesis pipeline by targeting the glutathione-dependent enzyme mPGES-1, a valuable macromolecular target in both cancer therapy and inflammation therapy. Specifically, by using a virtual fragment screening approach of aromatic bromides, straightforward...

Full description

Bibliographic Details
Main Authors: Simone Di Micco, Stefania Terracciano, Dafne Ruggiero, Marianna Potenza, Maria C. Vaccaro, Katrin Fischer, Oliver Werz, Ines Bruno, Giuseppe Bifulco
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2021.676631/full
_version_ 1818736344146378752
author Simone Di Micco
Stefania Terracciano
Dafne Ruggiero
Marianna Potenza
Maria C. Vaccaro
Katrin Fischer
Oliver Werz
Ines Bruno
Giuseppe Bifulco
author_facet Simone Di Micco
Stefania Terracciano
Dafne Ruggiero
Marianna Potenza
Maria C. Vaccaro
Katrin Fischer
Oliver Werz
Ines Bruno
Giuseppe Bifulco
author_sort Simone Di Micco
collection DOAJ
description We report the implementation of our in silico/synthesis pipeline by targeting the glutathione-dependent enzyme mPGES-1, a valuable macromolecular target in both cancer therapy and inflammation therapy. Specifically, by using a virtual fragment screening approach of aromatic bromides, straightforwardly modifiable by the Suzuki-Miyaura reaction, we identified 3-phenylpropanoic acid and 2-(thiophen-2-yl)acetic acid to be suitable chemical platforms to develop tighter mPGES-1 inhibitors. Among these, compounds 1c and 2c showed selective inhibitory activity against mPGES-1 in the low micromolar range in accordance with molecular modeling calculations. Moreover, 1c and 2c exhibited interesting IC50 values on A549 cell lines compared to CAY10526, selected as reference compound. The most promising compound 2c induced the cycle arrest in the G0/G1 phase at 24 h of exposure, whereas at 48 and 72 h, it caused an increase of subG0/G1 fraction, suggesting an apoptosis/necrosis effect.
first_indexed 2024-12-18T00:35:39Z
format Article
id doaj.art-71095209381047b3a5acfad96c27ae5e
institution Directory Open Access Journal
issn 2296-2646
language English
last_indexed 2024-12-18T00:35:39Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Chemistry
spelling doaj.art-71095209381047b3a5acfad96c27ae5e2022-12-21T21:27:01ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462021-05-01910.3389/fchem.2021.676631676631Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 InhibitionSimone Di Micco0Stefania Terracciano1Dafne Ruggiero2Marianna Potenza3Maria C. Vaccaro4Katrin Fischer5Oliver Werz6Ines Bruno7Giuseppe Bifulco8European Biomedical Research Institute of Salerno (EBRIS), Salerno, ItalyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyInstitute of Pharmacy, Friedrich-Schiller-University Jena, Jena, GermanyInstitute of Pharmacy, Friedrich-Schiller-University Jena, Jena, GermanyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyDipartimento di Farmacia, University degli Studi di Salerno, Fisciano, ItalyWe report the implementation of our in silico/synthesis pipeline by targeting the glutathione-dependent enzyme mPGES-1, a valuable macromolecular target in both cancer therapy and inflammation therapy. Specifically, by using a virtual fragment screening approach of aromatic bromides, straightforwardly modifiable by the Suzuki-Miyaura reaction, we identified 3-phenylpropanoic acid and 2-(thiophen-2-yl)acetic acid to be suitable chemical platforms to develop tighter mPGES-1 inhibitors. Among these, compounds 1c and 2c showed selective inhibitory activity against mPGES-1 in the low micromolar range in accordance with molecular modeling calculations. Moreover, 1c and 2c exhibited interesting IC50 values on A549 cell lines compared to CAY10526, selected as reference compound. The most promising compound 2c induced the cycle arrest in the G0/G1 phase at 24 h of exposure, whereas at 48 and 72 h, it caused an increase of subG0/G1 fraction, suggesting an apoptosis/necrosis effect.https://www.frontiersin.org/articles/10.3389/fchem.2021.676631/fullfragment-based approachSuzuki-Miyaura cross-couplingmPGES-1 inhibitorsanti-inflammatory drugsanticancer agents
spellingShingle Simone Di Micco
Stefania Terracciano
Dafne Ruggiero
Marianna Potenza
Maria C. Vaccaro
Katrin Fischer
Oliver Werz
Ines Bruno
Giuseppe Bifulco
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
Frontiers in Chemistry
fragment-based approach
Suzuki-Miyaura cross-coupling
mPGES-1 inhibitors
anti-inflammatory drugs
anticancer agents
title Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
title_full Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
title_fullStr Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
title_full_unstemmed Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
title_short Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition
title_sort identification of 2 thiophen 2 yl acetic acid based lead compound for mpges 1 inhibition
topic fragment-based approach
Suzuki-Miyaura cross-coupling
mPGES-1 inhibitors
anti-inflammatory drugs
anticancer agents
url https://www.frontiersin.org/articles/10.3389/fchem.2021.676631/full
work_keys_str_mv AT simonedimicco identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT stefaniaterracciano identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT dafneruggiero identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT mariannapotenza identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT mariacvaccaro identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT katrinfischer identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT oliverwerz identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT inesbruno identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition
AT giuseppebifulco identificationof2thiophen2ylaceticacidbasedleadcompoundformpges1inhibition